The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement / Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G.W., Chivato, T., Cruz, A.A., Czarlewski, W., Giacco, S.D., Du, H., Fonseca, J.A., Gao, Y., Haahtela, T., Hoffmann-Sommergruber, K., et al.. - In: ALLERGY. - ISSN 0105-4538. - (2020). [10.1111/all.14336]
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Iaccarino, GuidoMembro del Collaboration Group
;
2020
Abstract
The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
